Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: Follow-up from the Kronos Early Estrogen Prevention Study
Menopause Jan 04, 2019
Miller VM, et al. - In order to assess the progression of preclinical atherosclerosis upon cessation of menopausal hormone therapy (MHT), researchers evaluated changes in carotid artery intima-media thickness (CIMT) in a subgroup (n = 76) during 4 years and 3 years among the women enrolled in Kronos Early Estrogen Prevention Study (KEEPS) at Mayo Clinic (n = 118). KEEPS MHT assignments included placebo (PBO), n = 33; transdermal 17β-estradiol (tE2), n = 23; and oral conjugated equine estrogens group (oCEE), n = 20. Findings suggested no alteration in the trajectory of CIMT over a 3-year follow-up period, when cessation of MHT at the lower doses and formulations used in KEEPS was done. However, all groups displayed increased CIMT over the entire 7-year timeframe as expected with age and timing of menopause possibly key contributors.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries